Back to search

Article

Using explainable artificial intelligence to identify linguistic biomarkers of amyloid pathology in primary progressive aphasia

2024-05-05

Abstract excerpt

<h4>Introduction</h4> Recent success has been achieved in Alzheimer’s disease (AD) clinical trials targeting amyloid beta (β), demonstrating a reduction in the rate of cognitive decline. However, testing methods for amyloid-β positivity are currently costly or invasive, motivating the development of accessible screening approaches to steer patients toward appropriate diagnostic tests. Here, we employ a pre-trained...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b9514553-ce8a-5b78-bd63-d7768b0a8a9d
DOI
10.1101/2024.05.02.24306657
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Using explainable artificial intelligence to identify linguistic biomarkers of amyloid pathology in primary progressive aphasiaDOI 10.1101/2024.05.02.24306657
Select a neighboring publication to make it the new centre.